{"disease":{"id":"amyloid-cardiomyopathy-transthyretin-related","name":"amyloid cardiomyopathy transthyretin related"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03812172","title":"Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations","phase":"","overall_status":"COMPLETED","enrollment_count":646,"lead_sponsor_name":"Mathew S. Maurer, MD","has_results":true},{"nct_id":"NCT04988386","title":"Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":389,"lead_sponsor_name":"Eidos Therapeutics, a BridgeBio company","has_results":false},{"nct_id":"NCT03294707","title":"Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Eidos Therapeutics, a BridgeBio company","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}